
FDA OKs First-of-Its-Kind Lung Cancer Pill
July 7, 2025 – The FDA has granted quick approval to a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC). The drug, called sunvozertinib and sold as Zegfrovy, is for adults with advanced non-small-cell lung …